Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults
Clinical trial NCT04227210 · COMPLETED
Trial details
- NCT number
- NCT04227210
- Sponsor
- Meissa Vaccines, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-14
- Primary completion
- 2020-08-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.